This trial will test whether a laser treatment can improve the appearance of hypertrophic scars and scleroderma.
1 Primary · 3 Secondary · Reporting Duration: Up to 1 year after baseline
2 Treatment Groups
1 of 2
1 of 2
20 Total Participants · 2 Treatment Groups
Primary Treatment: Scleroderma · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the upper limit of individuals participating in this research project?
"Affirmative. According to clinicaltrials.gov, this research project is still enrolling participants and was initially made public on June 2nd 2021. The most recent update occurred on February 11th 2022; the study requires 20 patients from a single trial centre." - Anonymous Online Contributor
Are there any available vacancies in this experiment for participants?
"Indeed, the information hosted on clinicaltrials.gov attests to this trial's ongoing recruitment process which commenced June 2nd 2021 and was recently updated February 11th 2022. Currently, 20 individuals are being sought out from a single medical centre for inclusion in this study." - Anonymous Online Contributor